Introduction
Particulate guanylate cyclase [9] activity is stimulated by several hormones through membranereceptor mediated effects and by nitrosovasodilators through a direct, receptor independent mechanism. The end result is increased synthesis of intracellular 3'5'-cyclic guanosine monophosphate. The latter is thought to mediate vasodilation. The many and diverse effects of atrial natriuretic peptide (ANP) are brought about through specific plasma membrane ANP receptors, a subtype of which appears to be coupled to particulate guanylate cyclase [7, 8] . We and others have previously demonstrated the presence of ANP receptors in human placentas [5, 10] . In a preliminary report, it was shown that these receptors may be coupled to guanylate cyclase activity [11] , We have also presented data suggesting that the affinity of ANP placental receptors for alpha-hANP is decreased in association with severe toxemia of pregnancy [6] . Thus, we have asked the question whether a decrease in the affinity of ANP placental receptors for alpha-hANP is associated with a decrease in ANP-dependent guanylate cyclase activity. To complement the latter, we have also measured receptor-independent enzymatic stimulation by a nitrosovasodilator, sodium azide.
Materials and methods

Patients
They were randomly selected. Gestational ages ranged from 27-41 weeks. Severe toxemia of pregnancy was defined according to previously published ACOG criteria [1] . All control subjects were normotensive. 
Materials
Nonradioactive alpha-hANP (124-151) was obtained from Peninsula Laboratories. a-32 P-guanosine triphosphate (a-32 P-GTP, 25 Ci/mmol) and 3 H-3'5'-cyclic guanosine monophosphate ( 3 HcGMP, 16 Ci/mmol) were obtained from New England Nuclear. The other reagents were obtained commercially and were of the highest purity available.
Tissue
Human placentas from normal and severely toxemic pregnant patients were obtained at 27-41 weeks gestation immediately following delivery and placed on ice. Fetal membranes and large vessels were then removed by sharp dissection and the placenta was separated into fragments, each one weighing approximately 25 -50 grams. These aliquots were then frozen in liquid nitrogen and stored at -70 °C until needed for the assay. Under these conditions, no significant loss in ANP-receptor binding or ANP-dependent guanylate cyclase function was noted with freezing and storage for up to six months.
Membrane preparations [5]
On the day of the assay approximately 5 -10 grams of each placenta were allowed to thaw in 45 -50 ml of ice-cold, 0.9% sodium chloride (NaCl), 20 mM Tris hydrochloride (Tris-HCl), 250 mM sucrose, 5 mM ethylenediaminetetraacetic acid (EDTA), pH 7.5. All subsequent procedures were carried out at 4 °C. The placenta was minced with scissors and subsequently homogenized with a Brinkman polytron on setting #7, twice, each cycle lasting approximately 30 seconds with a 30 second cooling period between homogenizations. This crude homogenate was filtered through cheesecloth and spun at 40,000 χ g for 15 minutes. The pellet was resuspended and recentrifuged as before, twice. The pellet was resuspended in 0.9% NaCl, 20 mM Tris-HCl and 5mM ethylenebis-(oxyethylene-nitrilo)tetraacetic acid (EGTA), pH 7.5. The final concentration was approximately 4-10 mg of protein/ml.
Guanylate cyclase assay [4]
The conversion of oc-32 P-GTP to 32 P-cyclic-3'5' GMP was measured in this assay. Aliquots of placental membrane fragments (350 -600 μg protein/tube) were incubated at 37 °C for 10 minutes in an assay buffer that contained the following (final concentrations): l-methyl-3-isobutyxanthine (0.75 mM), theophylline (1 mM), creatine phosphate (10 mM), creatine phosphokinase (60 μg), manganese chloride (5 mM), magnesium chloride (5 mM), guanosine triphosphate (1 mM), 3'5'-cyclic GMP (cGMP) (0.5 mM), and approximately 3-5 χ 10 6 cpm of oc-32 P-GTP. The reaction was stopped with a solution containing sodium dodecyl sulfate (SDS, 2.5%), cyclic GMP (1 mM), GTP (2.5 mM), 20 mM Tris-HCl, pH 7.5. Ή-cGMP (approximately 2,000 -3,000 cpm per tube) was added to each tube to monitor the recovery. The suspension was boilded for 5 minutes. Cyclic GMP was isolated by sequential chromatography using Dowex (AG 50 W-X4) and alumina (WTO-neutral) columns. The recovery ranged from 40 -50%. Results have been corrected for recovery.
Basal enzymatic activity was measured in the absence of oc-hANP or sodium azide (NaN 3 ). Stimulation of guanylate cyclase activity was measured in the presence of oc-hANP (0.5 μηι) or NaN 3 (100 μιη) + catalase.
The amount of protein in the assay was determined by the method of Bradford [3] using bovine serum albumin as the standard. Radioactivity was counted in a scintillation counter. The results are presented as pmol of cyclic GMP generated per milligram of protein per 10 minutes. Statistical analysis is carried out by the Student t test and FISHER'S exact probability test. A p value of < 0.05 is considered as being statistically significant.
Results
The two groups were comparable with regards to maternal age, gravidity, parity, mode of delivery, and anesthesia (table I). All normal patients were normotensive and showed no proteinuria. In contrast, all toxemic patients were hypertensive (BP > 150/100) and demonstrated significant proteinuria (> 4.5 gm/24 hours). In addition, one patient showed thrombocytopenia and elevated liver enzymes. As expected, because of the severity of their disease, toxemic patients were delivered at an earlier point in gestation than the normal patients. Although the Apgar scores were similar in the two groups, there was one neonatal death in the toxemic group due to complications of prematurity. In the antepartum period, toxemic patients had received MgSO 4 and hydralazine. Table II shows guanylate cyclase activity in placentas from normal as well as severely toxemic patients. The results were normalized by log transformation of the data. Raw data were used for calculating the percent increase over basal activity. There was no significant difference with regards to basal guanylate cyclase activity between the two groups. However, stimulation of guanylate cyclase activity by ANP at the maximum concentration of ANP studied (0.5 μΜ) was higher in normal than in toxemic placentas. The percent increase of enzymatic activity compared to basal was significantly higher in placentas from normal patients than from severely toxemic patients.
We next measured stimulation of guanylate cyclase activity by a nitrovasodilator. We used sodium azide (NaN 3 ), with or without catalase. In some tissues, catalase has been found to be a necessary co-factor for NaN 3 -induced guanylate cyclase stimulation [9] . Guanylate cyclase was stimulated by NaN 3 but exhibited a higher degree of activity in the presence of catalase in both groups of patients (table III) . The percent stimulation over basal enzymatic activity was significantly higher in placentas from normal than in those from severely toxemic patients. f Mean + SEM; (n) = number of patients §(%) = % increase over basal activity * p = 0.048 ** p = 0.04l
Discussion
In these experiments we have demonstrated that there is an ANP-dependent guanylate cyclase activity in placentas obtained both from normal and severly toxemic patients. Moreover, we have shown that although the basal activities are similar, the percent increase in ANP-dependent guanylate cyclase activity is lower in toxemic placentas than in placentas from normal women at term. Finally, the percent increase in nitrovasodilatorinduced (NaN 3 ) placental guanylate cyclase activity was also lower in toxemic than in normal patients.
Guanylate cyclase is thought to be involved in regulating vascular tone [9] . Stimulation of this enzyme results in intra-cellular release of cyclic GMP. The latter is thought to mediate vasodilation. Several hormones, including ANP, stimulate guanylate cyclase through binding to specific membrane receptors. Another class of compounds, the so-called nitrosovasodilators, stimulate this enzyme directly via a nitric oxide dependent mechanism. In either case, production of cGMP is presumed to induce phosphorylation of similar or identical substrates that ultimately mediate vasodilation.
The role of cGMP in terms of placental hemodynamics has not been adequately investigated. Basal guanylate cyclase activity may not necessarily reflect the functional properties of the tissue. Thus, we chose to examine this enzymatic activity in a more dynamic fashion, i.e. stimulated activity. Our observation that the stimulated cyclase activity is reduced in placentas from toxemic patients suggests that there might be an association between certain aspects of placental hemodynamic regulation and guanylate cyclase activity. While ANP appears to be an important factor in terms of guanylate cyclase stimulation in placental plasma membranes, it is by no means the only factor that may influence its overall function. This is supported by our results concerning NaN 3 -dependent enzymatic activity. However, in placentas for severely toxemic patients, the percent stimulation of guanylate cyclase activity is decreased both in the case of ANP as well as in the case of a nitrosovasodilator, NaN 3 .
ANP effects are mediated through specific plasma ANP receptors. One subtype of these receptors is coupled to guanylate cyclase [7, 8] . A second subtype of ANP receptor has been shown to mediate its effects independent of guanylate cyclase [7] . However, in the latter case, the nature of the second messenger is not known. Although guanylate caclase is found both in the plasma membrane as well as in cytoplasmic fractions, as these experiments suggest and as we have previously discussed, placental ANP receptors are presumed to be located in a microsomal plasma membrane fraction which is thought to be exposed primarily to fetal blood [ [2] . It is not known whether fetal ANP levels are altered in toxemia of pregnancy. Further experiments need to be designed to answer these specific questions.
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cyclase activity was demonstrated both in normal and toxemic placentas. Although basal guanylate cyclase activity was not influenced by toxemia of pregnancy, there was a significant decrease in the maximum stimulation of this enzyme by a-hANP (104.81 ± 12.02% (n = 4) vs 49.41 ± 8.73% (n = 7) for normal and toxemics, respectively). Finally, stimulation by a nitrosovasodilator, sodium azide (NaN 3 ), was also lower in toxemic placentas than in normal controls. These observations extend our previously reported results on placental ANP receptor function but also suggest the presence of a possibly receptor-independent decrease in guanylate cyclase activity in toxemic placentas. Bien que l'activite guanylate cyclase de base exprimee en log (pmol/mg de proteine/min) ne soit pas influencee par la toxemie gravidique (normal = 2,231 ± 0,703 (n = 4); toxemie: 1,955 + 0,196; n = 7) il y a une diminution significative de la stimulation de cette enzyme par 1'a-hANE (104,81 ± 12,02 versus 49,41 ± 8,73% respectivement pour la normale et la toxemie). La stimulation par un nitrosovasodilatateur, le sodium azide, est egalement plus faible dans les placentas de toxemiques que dans les placentas temoins normaux (102,11 ± 28,04% VS 198,95 ± 19,86%). On pense que la guanylate cyclase est impliquee dans la regulation du tonus vasculaire. La stimulation de cette enzyme entraine une liberation intracellulaire de GMP cyclique qui peut induire une vasodilatation. Le role du CGMP en terme d'hemodynamique placentaire n'a pas ete explore de fagon adequate. Les observations que nous presentons suggerent qu'il pourrait y avoir une relation entre certains aspects de la regulation de rhemodynamique placentaire et l'activite guanylate cyclase. Bien que ΓΑΝΡ semble etre un facteur important en ce qui concerne la stimulation de la gyanylate cyclase dans les membranes du plasma placentaire, ce n'est surement pas 1'unique facteur qui peut influencer s fonction globale. Nos resultats concernant l'activite enzymatique sodium azide dependante renforce cette opinion. Neanmoins, la stimulation de l'enzyme diminue avec ΓΑΝΡ aussi bien qu'avec le sodium azide, nitrosovasodilatateur. Ces observations renforcent la diminution de Faffinite pour Fa-hANP des recepteurs ANP placentaires chez les toxemiques que nous avions anterieurement rapportee. Toutefois, les observations ne permettent pas de repondre a la question de savoir si cette diminution est primitive ou secondaire chez les patientes ayant une toxemie gravidique. D'autres experiences sont necessaires pour repondre ces questions specifiques.
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